These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 26246396)
1. Venipuncture does not affect adrenocorticotropic hormone concentration in horses. Fouché N; van der Kolk JH; Bruckmaier RM; Luz I; Foerster G; Gerber V Vet Rec; 2015 Sep; 177(9):223. PubMed ID: 26246396 [No Abstract] [Full Text] [Related]
2. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia. Beech J; Boston R; Lindborg S; Russell GE J Am Vet Med Assoc; 2007 Aug; 231(3):417-26. PubMed ID: 17669045 [TBL] [Abstract][Full Text] [Related]
3. Investigation of rhythms of secretion and repeatability of plasma adrenocorticotropic hormone concentrations in healthy horses and horses with pituitary pars intermedia dysfunction. Rendle DI; Litchfield E; Heller J; Hughes KJ Equine Vet J; 2014 Jan; 46(1):113-7. PubMed ID: 23742059 [TBL] [Abstract][Full Text] [Related]
4. The use of adrenocorticotrophic hormone as a potential biomarker of pituitary pars intermedia dysfunction in horses. Lee ZY; Zylstra R; Haritou SJ Vet J; 2010 Jul; 185(1):58-61. PubMed ID: 20537574 [TBL] [Abstract][Full Text] [Related]
5. Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction. Copas VE; Durham AE Equine Vet J; 2012 Jul; 44(4):440-3. PubMed ID: 21848531 [TBL] [Abstract][Full Text] [Related]
6. Comparison of cortisol and ACTH responses after administration of thyrotropin releasing hormone in normal horses and those with pituitary pars intermedia dysfunction. Beech J; Boston R; Lindborg S J Vet Intern Med; 2011; 25(6):1431-8. PubMed ID: 22092639 [TBL] [Abstract][Full Text] [Related]
7. α-Melanocyte--stimulating hormone and adrenocorticotropin concentrations in response to thyrotropin-releasing hormone and comparison with adrenocorticotropin concentration after domperidone administration in healthy horses and horses with pituitary pars intermedia dysfunction. Beech J; McFarlane D; Lindborg S; Sojka JE; Boston RC J Am Vet Med Assoc; 2011 May; 238(10):1305-15. PubMed ID: 21568777 [TBL] [Abstract][Full Text] [Related]
8. The effects of sample handling and N-phenylmaleimide on concentration of adrenocorticotrophic hormone in equine plasma. Rendle DI; Litchfield E; Gough S; Cowling A; Hughes KJ Equine Vet J; 2015 Sep; 47(5):587-91. PubMed ID: 24980684 [TBL] [Abstract][Full Text] [Related]
9. The effect of freeze-thaw cycles on determination of immunoreactive plasma adrenocorticotrophic hormone concentrations in horses. Hu K; Stewart AJ; Yuen KY; Hinrichsen S; Dryburgh EL; Bertin FR J Vet Intern Med; 2020 May; 34(3):1350-1356. PubMed ID: 32255541 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of combined testing to simultaneously diagnose pituitary pars intermedia dysfunction and insulin dysregulation in horses. Horn R; Bertin FR J Vet Intern Med; 2019 Sep; 33(5):2249-2256. PubMed ID: 31498947 [TBL] [Abstract][Full Text] [Related]
12. Investigation of single and paired measurements of adrenocorticotropic hormone for the diagnosis of pituitary pars intermedia dysfunction in horses. Rendle DI; Duz M; Beech J; Parkin T; Durham AE J Vet Intern Med; 2015 Jan; 29(1):355-61. PubMed ID: 25312676 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of plasma ACTH, alpha-melanocyte-stimulating hormone, and insulin concentrations during various photoperiods in clinically normal horses and ponies and those with pituitary pars intermedia dysfunction. Beech J; Boston RC; McFarlane D; Lindborg S J Am Vet Med Assoc; 2009 Sep; 235(6):715-22. PubMed ID: 19751169 [TBL] [Abstract][Full Text] [Related]
14. Alpha-melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants. McFarlane D; Beech J; Cribb A Domest Anim Endocrinol; 2006 May; 30(4):276-88. PubMed ID: 16115743 [TBL] [Abstract][Full Text] [Related]
15. Comparison of two methods for measurement of equine adrenocorticotropin. Banse HE; Schultz N; McCue M; Geor R; McFarlane D J Vet Diagn Invest; 2018 Mar; 30(2):233-237. PubMed ID: 29284383 [TBL] [Abstract][Full Text] [Related]
16. Circadian and circannual rhythms of cortisol, ACTH, and α-melanocyte-stimulating hormone in healthy horses. Cordero M; Brorsen BW; McFarlane D Domest Anim Endocrinol; 2012 Nov; 43(4):317-24. PubMed ID: 22717182 [TBL] [Abstract][Full Text] [Related]
17. Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction. Miller MA; Pardo ID; Jackson LP; Moore GE; Sojka JE Vet Pathol; 2008 Jan; 45(1):26-38. PubMed ID: 18192571 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic testing for pituitary pars intermedia dysfunction in horses. Dybdal NO; Hargreaves KM; Madigan JE; Gribble DH; Kennedy PC; Stabenfeldt GH J Am Vet Med Assoc; 1994 Feb; 204(4):627-32. PubMed ID: 8163420 [TBL] [Abstract][Full Text] [Related]
19. Circannual variability in adrenocorticotropic hormone responses to administration of thyrotropin-releasing hormone in clinically normal horses in Australia. Byrne DP; Secombe CJ; Tan RHH; Perera DI; Watts SP; Wearn JG Vet J; 2018 Aug; 238():58-62. PubMed ID: 30103916 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the sensitivity and specificity of basal plasma adrenocorticotrophic hormone concentration for diagnosing pituitary pars intermedia dysfunction in horses: A systematic review. Tatum RC; McGowan CM; Ireland JL Vet J; 2021 Sep; 275():105695. PubMed ID: 34099343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]